ArticleGHM open2022
Global landscape of the COVID-19 vaccination policy: Ensuring equitable access to quality-assured vaccines.
Article in GHM open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ensuring equitable access to COVID-19 vaccines for all people has been challenging, hence, establishing relevant vaccination policies is required. This study delineates how vaccination policies have affected equitable access to COVID-19 vaccines. A situation survey was conducted in 201 countries and territories through 156 Japanese diplomatic missions abroad to capture the global state of COVID-19 vaccination policies. Questionnaire responses were received from 159 states (79%) as of March 31, 2021, and data from Japan were incorporated into the analysis. All questionnaire items were open-ended, covering the vaccines in use and five vaccination policies such as vaccine eligibility. Results reveal that first, 81 states (51% out of 160) had not started vaccinations as of February 24, 2021, but by March 31, this number had decreased dramatically to 37 (23%); in particular, the number of states in Africa without vaccination decreased from 40 to 16. Second, 43 (27%) states did not recommend the vaccine for pregnant women. Third, the vaccine was free of charge to the public in 116 states (73%), and 43 states (27%) offered no-fault compensation. Finally, vaccination was voluntary in 124 states (78%). In conclusion, the number of countries that had started vaccination increased by March 2021, especially in Africa, although many African countries seemed to lack access to the mRNA vaccine. To fix the uneven distribution, dose donations were accelerated since middle of July. Reviewing worldwide vaccine policies is useful not only for this pandemic but also to strengthen vaccination systems for preparedness for the next pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.